Mutant allele-specific imbalance modulates prognostic impact of KRAS mutations in colorectal adenocarcinoma and is associated with worse overall survival
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mutant allele-specific imbalance modulates prognostic impact of KRAS mutations in colorectal adenocarcinoma and is associated with worse overall survival
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 131, Issue 8, Pages 1810-1817
Publisher
Wiley
Online
2012-01-31
DOI
10.1002/ijc.27461
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pathogenesis and Consequences of Uniparental Disomy in Cancer
- (2011) H. Makishima et al. CLINICAL CANCER RESEARCH
- Higher Dosage of the Epidermal Growth Factor Receptor Mutant Allele in Lung Adenocarcinoma Correlates with Younger Age, Stage IV at Presentation, and Poorer Survival
- (2011) Gerard J. Oakley et al. Journal of Thoracic Oncology
- KRAS mutant allele-specific imbalance in lung adenocarcinoma
- (2011) Simion I Chiosea et al. MODERN PATHOLOGY
- EGFR fluorescence in situ hybridization-positive lung adenocarcinoma: incidence of coexisting KRAS and BRAF mutations
- (2010) Simion Chiosea et al. HUMAN PATHOLOGY
- Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab
- (2010) Wendy De Roock et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- In Situ Evidence of KRAS Amplification and Association With Increased p21 Levels in Non–Small Cell Lung Carcinoma
- (2009) Patrick L. Wagner et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Integrative approach for prioritizing cancer genes in sporadic colon cancer
- (2009) James F. Reid et al. GENES CHROMOSOMES & CANCER
- American Society of Clinical Oncology Provisional Clinical Opinion: Testing forKRASGene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Therapy
- (2009) Carmen J. Allegra et al. JOURNAL OF CLINICAL ONCOLOGY
- KRAS Mutations and Sensitivity to Epidermal Growth Factor Receptor Inhibitors in Colorectal Cancer: Practical Application of Patient Selection
- (2009) Antonio Jimeno et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B andKRASmutations in colorectal carcinoma
- (2009) Jehad Abubaker et al. JOURNAL OF PATHOLOGY
- Oncogenic Activating Mutations Are Associated with Local Copy Gain
- (2009) B. Modrek et al. MOLECULAR CANCER RESEARCH
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
- (2009) Eric Van Cutsem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alterations in Genes of the EGFR Signaling Pathway and Their Relationship to EGFR Tyrosine Kinase Inhibitor Sensitivity in Lung Cancer Cell Lines
- (2009) Jeet Gandhi et al. PLoS One
- Oncogene Mutations, Copy Number Gains and Mutant Allele Specific Imbalance (MASI) Frequently Occur Together in Tumor Cells
- (2009) Junichi Soh et al. PLoS One
- Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
- (2008) Rafael G. Amado et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now